1.0-1 | Patency check of every lumen | 0 |
1.0-1b | Sterile saline flush with aspiration attempt | 0 |
1.0-2 | Classify the occlusion type | 0 |
1.0-3 | Investigate the blocked lumen promptly | 0 |
1.0-4 | No occluded lumen left untreated | 0 |
1.0-5 | Document patency and occlusion signs | 0 |
2.0-1 | Screen for mechanical occlusion | 0 |
2.0-2 | Assess for a positional device | 0 |
2.0-2a | Repositioning measures for a positional CVAD | 0 |
2.0-2d | Screen subclavian devices for pinch-off | 0 |
2.0-3 | Inspect and palpate for device damage | 0 |
2.0-4 | Act on reports suggesting tip malposition | 0 |
2.0-5 | Clear the mechanical obstruction | 0 |
2.0-5a | Hub flush once add-on devices are removed | 0 |
2.0-5b | Check dressing and catheter for kinks | 0 |
2.0-5c | Verify the non-coring needle position | 0 |
2.0-5d | Replace a clogged filter | 0 |
2.0-5e | Replace tight sutures with sutureless securement | 0 |
2.0-5f | Non-invasive correction of confirmed malposition | 0 |
2.0-5g | Power flushing by a vascular access specialist | 0 |
2.0-5h | Repair or replace a damaged device | 0 |
2.0-6 | Radiographic check of tip position | 0 |
2.0-6a | Pause infusion when malposition is suspected | 0 |
2.0-6b | Remove the device when pinch-off is confirmed | 0 |
2.0-7 | Update the plan of care with prevention steps | 0 |
2.0-8 | Document findings, actions and response | 0 |
3.0-1 | Look for signs of thrombotic occlusion | 0 |
3.0-1a | Saline approach when blood return is absent | 0 |
3.0-1b | Small-barrel syringe for aspiration only | 0 |
3.0-1c | Dye study for unresolved occlusion | 0 |
3.0-2 | Try to save the CVAD before replacement | 0 |
3.0-3 | Give alteplase promptly for suspected occlusion | 0 |
3.0-3a | Follow organisational policy for thrombolysis | 0 |
3.0-3b | Heparin does not restore patency | 0 |
3.0-3c | Consent, order and infection risk before alteplase | 0 |
3.0-3d | Competency for thrombolytic administration | 0 |
3.0-3e | Treat every occluded lumen | 0 |
3.0-3f | Risk-benefit analysis for multi-lumen occlusion | 0 |
3.0-3g | Treat older occlusions too | 0 |
3.0-3h | Stop infusions during dwell time | 0 |
3.0-4 | Alteplase dose and dwell time | 0 |
3.0-4a | How to instil alteplase | 0 |
3.0-4b | Dwell time of 30 minutes to 2 hours | 0 |
3.0-4c | Extended dwell for fibrin sheath | 0 |
3.0-4d | Aspirate waste and flush after dwell | 0 |
3.0-5 | Alternatives for recurrent occlusion | 0 |
3.0-5a | Push method over 30 minutes | 0 |
3.0-5b | Dual syringe technique for ports | 0 |
3.0-5c | Low-dose infusion for fibrin sheath | 0 |
3.0-6a | Notify MRP and consider imaging | 0 |
3.0-6b | Removal with an alternative access plan | 0 |
3.0-6c | Investigate for CVAD thrombosis | 0 |
3.0-7 | Monitor after thrombolytic for infection and thrombosis | 0 |
3.0-8 | Update care plan with prevention strategies | 0 |
3.0-9 | Document the occlusion episode | 0 |
4.0-1 | Assess for chemical occlusion | 0 |
4.0-2 | Clear chemical occlusion promptly | 0 |
4.0-2a | Follow policy for chemical clearance | 0 |
4.0-2b | Competent staff only for chemical clearance | 0 |
4.0-2c | Discuss risks and obtain an order | 0 |
4.0-2d | Direct instillation for partial occlusion | 0 |
4.0-2e | Negative pressure for complete occlusion | 0 |
4.0-2f | Fill volume only | 0 |
4.0-3 | Notify MRP if clearance fails | 0 |
4.0-4 | Consider a thrombolytic after chemical failure | 0 |
4.0-5 | Revise care plan to prevent recurrence | 0 |
4.0-6 | Document chemical occlusion care | 0 |
5.0-1 | Educate and validate competency | 0 |
5.0-2 | Track outcomes of occlusion | 0 |
5.0-3 | Consider occlusion-prevention products | 0 |
5.0-M1 | Record device type and position | 0 |
5.0-M2 | Record patient demographics | 0 |
5.0-M3 | Record care setting | 0 |
5.0-M4 | Record therapies given through the device | 0 |
5.0-M5 | Record occlusion date and lumen | 0 |
5.0-M6 | Record the type of occlusion | 0 |
5.0-M7 | Record thrombolytic doses given | 0 |
5.0-M8 | Record the instillation method | 0 |
5.0-M9 | Record clearance outcomes and complications | 0 |
INTRO-01 | Why the guideline exists | 0 |
INTRO-02 | Aim and intended audience | 0 |
INTRO-03 | What the guideline covers and excludes | 0 |
INTRO-04 | How recommendations were developed | 0 |